| [1]Kidney Disease Improving Global Outcome KDIGO.Acute kidney injury work group:KDIGO linical practice guideline for acute kidney injury[J].Kidney Int, 2012, 2(Suppl):1-138
[2]Zhang Z, Hongying N.Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy[J].Intensive Care Med, 2012, 38(1):20-28
[3]Bai M, Zhou M, He L, et al.Citrate versus heparin anticoagulation for continuous renal replacement therapy: an updated meta-analysis of RCTs[J].Intensive Care Med, 2015, 41(12):2098-2110
[4]Rogers AR, Jenkins B.Calorie provision from citrate anticoagulation in continuous renal replacement therapy in critical care[J].J Intensive Care Soc, 2021, 22(3):183-186
[5]Khadzhynov D, Schelter C, Lieker I, et al.Incidence and outcome of metabolic disarrang-ements consistent with citrate accumulation in critically ill patients undergo-ing continuous venovenous hemodialysis with regional citrate anticoagulation[J].J Crit Care, 2014, 29(2):265-271
[6]Hetzel GR, Taskaya G, Sucker C, et al.Citrate plasma levels in patients under regionala?nticoagulation in continuous venovenous hemofiltration[J].Am J Kidney Dis, 2006, 48(5):806-811
[7]Meier-Kriesche HU, Gitomer J, Finkel K, et al.Increased total to ionized calcium ratio d-uring continuous venovenous hemodialysis with regional citrate anticoagulation[J].Crit Care Med, 2001, 29(4):748-752
[8]Schulthei? C, Saugel B, Phillip V, et al.Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study[J].Crit Care, 2012, 16(4):R162-
[9]Schwarzer P, Kuhn SO, Stracke S, et al.Discrepant post filter ionized calcium concentrations by common blood gas analyzers in CRRT using regional citrate antico-agulation[J].Crit Care, 2015, 19(1):321-
[10]Mariano F, Morselli M, Bergamo D, et al.Blood and ultrafiltrate dosage of citrate as a u?se?ful and routine tool during continuous venovenous haemodiafiltration in septic shock patients[J].Nephrol Dial Transplant, 2011, 26(12):3882-3888
[11]Rêgo F Portela F, Santos MF.Towards PWA in Healthcare[J].Proced Computer Sci, 2019, 160:678-683
[12]Szamosfalvi B, Heung M, Yessayan L.Technology Innovations in Continuous Kidney Replacement Therapy: The Clinician's Perspective[J].Adv Chronic Kidney Dis, 2021, 28(1):3-12
[13]龚德华, 季大玺, 徐斌, 等.枸橼酸钠抗凝在重危患者连续性血液净化治疗中的应用[J].中华内科杂志, 2003, 42(02):121-122
[14]Zhao Y, Li Z, Zhang L, et al.Citrate versus heparin lock for hemodialysis catheters: a s-ystematic review and meta-analysis of randomized controlled trials[J].Am J Kidney Dis, 2014, 63(3):479-490
[15]Potier J, Dolley-Hitze T, Hamel D, et al.Long-term effects of citric acid-based bicarbonate haemodialysis on patient outcomes: a survival propensity score-matched study in western France[J].Nephrol Dial Transplant, 2020, 35(7):1228-1236
[16]Wen M, Küchle C, Steubl D, et al.A novel citrate-based protocol versus heparin anticoa-gultion for sustained low-efficiency dialysis in the ICU: safety,efficacy,and cost[J].BMC Nephrol, 2018, 19(1):79-
[17]Kissling S, Legallais C, Pruijm M, et al.A new prescription model for regional citrate anticoagulation in therapeutic plasma exchanges[J].BMC Nephrol, 2017, 18(1):81-
[18]Ponikvar R, Guben?ek J, Ponikvar JB.Citrate Anticoagulation in Tandem Membrane Plasma Exchange or Immunoadsorption and Hemodialysis in Patients With Immuno-logical Diseases and Dialysis-Dependence[J].Ther Apher Dial, 2016, 20(3):246-250
|
